AVNSAVANOS MEDICAL, INC.

NYSE avanos.com


$ 19.91 $ 0.01 (0.05 %)    

Thursday, 28-Mar-2024 15:59:58 EDT
QQQ $ 443.93 $ -0.82 (-0.18 %)
DIA $ 397.72 $ 0.20 (0.05 %)
SPY $ 523.07 $ -0.10 (-0.02 %)
TLT $ 94.55 $ -0.08 (-0.08 %)
GLD $ 205.72 $ 2.62 (1.29 %)
$ 19.91
$ 19.93
$ 0.00 x 0
$ 0.00 x 0
$ 19.91 - $ 20.11
$ 17.24 - $ 31.31
232,958
na
919.9M
$ 1.31
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-21-2024 12-31-2023 10-K
2 11-01-2023 09-30-2023 10-Q
3 08-09-2023 06-30-2023 10-Q
4 05-03-2023 03-31-2023 10-Q
5 02-21-2023 12-31-2022 10-K
6 11-02-2022 09-30-2022 10-Q
7 08-09-2022 06-30-2022 10-Q
8 05-04-2022 03-31-2022 10-Q
9 02-23-2022 12-31-2021 10-K
10 11-02-2021 09-30-2021 10-Q
11 08-03-2021 06-30-2021 10-Q
12 05-07-2021 03-31-2021 10-Q
13 02-19-2021 12-31-2020 10-K
14 11-03-2020 09-30-2020 10-Q
15 08-04-2020 06-30-2020 10-Q
16 05-06-2020 03-31-2020 10-Q
17 02-25-2020 12-31-2019 10-K
18 11-05-2019 09-30-2019 10-Q
19 08-06-2019 06-30-2019 10-Q
20 05-07-2019 03-31-2019 10-Q
21 02-26-2019 12-31-2018 10-K
22 11-06-2018 09-30-2018 10-Q
23 08-07-2018 06-30-2018 10-Q
24 05-02-2018 03-31-2018 10-Q
25 02-27-2018 12-31-2017 10-K
26 11-01-2017 09-30-2017 10-Q
27 08-02-2017 06-30-2017 10-Q
28 05-02-2017 03-31-2017 10-Q
29 02-27-2017 12-31-2016 10-K
30 11-03-2016 09-30-2016 10-Q
31 08-05-2016 06-30-2016 10-Q
32 05-09-2016 03-31-2016 10-Q
33 02-29-2016 12-31-2015 10-K
34 11-04-2015 09-30-2015 10-Q
35 08-12-2015 06-30-2015 10-Q
36 05-05-2015 03-31-2015 10-Q
37 03-13-2015 12-31-2014 10-K
38 11-20-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 avanos-medical-voluntarily-recalled-specific-lots-of-mic-gastric--jejunal-feeding-tube-kits-in-response-to-nurse-assist-sterile-water-medical-products-recall

The Nurse Assist voluntary recall was initiated due to concerns about the potential lack of sterility assurance in these water-...

 correction-avanos-medical-q4-adj-eps-036-misses-037-estimate-sales-17330m-beat-17043m-estimate

Avanos Medical (NYSE:AVNS) reported quarterly earnings of $0.36 per share which missed the analyst consensus estimate of $0.37 ...

 avanos-medical-expects-2024-net-sales-of-685m-705m-vs-69013m-est-adj-eps-of-130-145-vs-138-est

2024 Outlook The Company expects 2024 net sales to be between $685 and $705 million, which assumes organic growth between 3% t...

 earnings-scheduled-for-february-20-2024

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue...

 why-mobileye-global-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23...

 avanos-medical-inc-reports-preliminary-q4-and-fy23-financial-results-revises-preliminary-2024-revenue-outlook-sees-q4-revenue-170m-173m-vs-17927m-est-fy23-revenue-670m-673m-vs-67927m-est--fy24-revenue-685m-705m-vs-71443m-est

Avanos Medical, Inc. (NYSE:AVNS) today reported selected, unaudited preliminary financial results for the fourth quarter and fu...

 garmin-apollo-global-management-trane-technologies-scotts-miracle-gro-and-other-big-stocks-moving-higher-on-wednesday

U.S. stocks traded higher, with the Dow Jones falling more than 30 points on Wednesday. Here are some big stocks recording gain...

 earnings-scheduled-for-november-1-2023

Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of...

 avanos-medical-q3-adj-eps-030-beats-028-estimate-sales-17130m-beat-16960m-estimate

Avanos Medical (NYSE:AVNS) reported adjusted quarterly earnings of $0.30 per share which beat the analyst consensus estimate of...

 avanos-medical-expects-adjusted-diluted-eps-of-105-115-for-fy23-vs-consensus-of-152

For the second half of 2023, Avanos Medical, Inc.(NYSE:AVNS) anticipates low single-digit organic growth, adjusted gross margin...

 avanos-medical-q2-adj-eps-024-misses-030-estimate-sales-16940m-miss-18622m-estimate

Avanos Medical (NYSE:AVNS) reported adjusted quarterly earnings of $0.24 per share which missed the analyst consensus estimate ...

 earnings-scheduled-for-august-9-2023

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earnings at $0.96 per share on r...

 keybanc-downgrades-avanos-medical-to-sector-weight

Keybanc analyst Matthew Mishan downgrades Avanos Medical (NYSE:AVNS) from Overweight to Sector Weight.

 stifel-reiterates-hold-on-avanos-medical-maintains-25-price-target

Stifel analyst Rick Wise reiterates Avanos Medical (NYSE:AVNS) with a Hold and maintains $25 price target.

 avanos-medical-earlier-monday-announced-agreement-to-acquire-diros-technology-terms-not-disclosed

- Avanos Medical, Inc. (NYSE:AVNS) today announced it has entered into a definitive agreement to acquire Diros Technology Inc.,...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION